{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:39Z","timestamp":1787027319192,"version":"build-2736575974"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Stroke"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Nigeria has the highest proportion of children with sickle cell anemia (SCA) globally; without transcranial Doppler screening and ongoing treatment (regular blood transfusions or hydroxyurea therapy), 10% will have a stroke in childhood. In low-resource settings, training to recognize and prevent strokes in children with SCA is vital. A sustainable\n                      <jats:italic>Sickle Cell Disease Stroke Prevention Teams<\/jats:italic>\n                      program was established, as part of clinical trials, to address the need for stroke care in northern Nigeria. We describe our health professional stroke training curriculum and specific application to detect strokes in clinical trials in low-resource settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Children aged 5\u201312 and 2\u201316 years with SCA in northern Nigeria were enrolled in the SPRING and SPRINT primary and secondary stroke prevention trials, respectively. The primary outcome measure in both trials was a clinical stroke based on the World Health Organization definition. Non-neurologist physicians were trained in-person and via video lectures regarding stroke recognition, performing neurological examinations using the adapted Pediatric NIH Stroke Scale, and acute stroke care. Central stroke adjudicators, two pediatric neurologists, reviewed the case report forms and recorded videos of the neurological examinations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six physicians completed the curriculum at three sites and were certified to detect strokes. Of 20 children with suspected stroke, 8 and 11 children had acute initial or acute recurrent strokes confirmed in the SPRING (\n                      <jats:italic>N<\/jats:italic>\n                      = 220) and SPRINT (\n                      <jats:italic>N<\/jats:italic>\n                      = 101) trials, respectively. The concordance rate between local stroke diagnoses and the central stroke adjudication process was 95% (19 of 20). One child presented with non-specific symptoms and hypertonia and was mislabeled locally as an acute stroke.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>A curriculum to train healthcare providers in pediatric acute stroke recognition and care in a low-resource setting is feasible and sustainable. We successfully identified strategies for task shifting from a single pediatric neurologist in the region to multiple non-neurologist physicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fstro.2024.1444718","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T23:24:52Z","timestamp":1736119492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying strokes in Nigerian children with sickle cell disease as part of clinical trials: training curriculum for healthcare professionals in low-income settings"],"prefix":"10.3389","volume":"3","author":[{"given":"Djamila L.","family":"Ghafuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Bello-Manga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenella J.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Ciobanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Trevathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rodeghier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"DeBaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S2352-3026(21)00368-9","article-title":"Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Lancet Haematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/blood.2022016620","article-title":"Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial","volume":"141","author":"Abdullahi","year":"2023","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.410420505","article-title":"Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler","volume":"42","author":"Adams","year":"1997","journal-title":"Ann. Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N. Engl. J. Med"},{"key":"B5","first-page":"113","article-title":"Cerebrovascular disease in the community: results of a WHO collaborative study","volume":"58","author":"Aho","year":"1980","journal-title":"Bull. World Health Organ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2352-3026(21)00191-5","article-title":"Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care","volume":"8","author":"Esoh","year":"2021","journal-title":"Lancet Haematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3518402","DOI":"10.1155\/2017\/3518402","article-title":"Efficacy and safety of manual partial red cell exchange in the management of severe complications of sickle cell disease in a developing country","volume":"2017","author":"Faye","year":"2017","journal-title":"Adv. Hematol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1002\/ajh.25900","article-title":"Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: final results of the SPIN trial","volume":"95","author":"Galadanci","year":"2020","journal-title":"Am. J. Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pediatrneurol.2021.08.010","article-title":"Capacity building for primary stroke prevention teams in children living with sickle cell anemia in Africa","volume":"125","author":"Ghafuri","year":"2021","journal-title":"Pediatr. Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1001\/jamaneurol.2016.0992","article-title":"Association of blood pressure, blood glucose, and temperature with neurological outcome after childhood stroke","volume":"73","author":"Grelli","year":"2016","journal-title":"JAMA Neurol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform"},{"key":"B14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform"},{"key":"B15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/STROKEAHA.110.607192","article-title":"Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study","volume":"42","author":"Ichord","year":"2011","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/pbc.24698","article-title":"Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal","volume":"60","author":"Lagunju","year":"2013","journal-title":"Pediatric Blood Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2333794X","DOI":"10.1177\/2333794X18774970","article-title":"Stroke prevalence in children with sickle cell disease in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"5","author":"Marks","year":"2018","journal-title":"Glob Pediatr. Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000073977","article-title":"Validity and reliability of the \u2018Ten Questions' questionnaire for detecting moderate to severe neurological impairment in children aged 6-9 years in rural Kenya","volume":"23","author":"Mung'ala-Odera","year":"2004","journal-title":"Neuroepidemiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/neurintsurg-2014-011572","article-title":"Intracranial aneurysms in sickle cell anemia: clinical and imaging findings","volume":"8","author":"Nabavizadeh","year":"2016","journal-title":"J. NeuroInterv. Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars","year":"1978","journal-title":"Am. J. Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"key":"B22","unstructured":"Sickle-cell anaemia: report by the Secretariat.2006"},{"key":"B23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2431-11-93","article-title":"Can the FAST and ROSIER adult stroke recognition tools be applied to confirmed childhood arterial ischemic stroke?","volume":"11","author":"Yock-Corrales","year":"2011","journal-title":"BMC Pediatr"}],"container-title":["Frontiers in Stroke"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fstro.2024.1444718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T23:24:57Z","timestamp":1736119497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fstro.2024.1444718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":23,"alternative-id":["10.3389\/fstro.2024.1444718"],"URL":"https:\/\/doi.org\/10.3389\/fstro.2024.1444718","relation":{},"ISSN":["2813-3056"],"issn-type":[{"value":"2813-3056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1444718"}}